Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD4CAR T Cell Therapy for CMML

NCT06071624 is registered in ClinicalTrials.gov with Huda Salman as lead sponsor.

NCT NCT06071624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06071624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD4CAR T Cell Therapy for CMML
Lead sponsor
Huda Salman
Phase
Phase 1
Overall status
Suspended
Start date
February 21, 2024
Completion date
December 31, 2043
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia